Drug intelligence / Profile preview

Agnurell

Development stage
Unknown
Lead developer
Sanorell Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Agnurell is a homeopathic medicinal product developed and marketed by Sanorell Pharma. Its primary active ingredient is a homeopathic dilution (typically D2) of *Vitex agnus-castus*, commonly known as Chaste tree or Chasteberry. The product is indicated for the treatment of gynecological conditions, including menstrual cycle irregularities, mastodynia (breast pain and swelling), and premenstrual syndrome (PMS). The therapeutic effect of the *Vitex agnus-castus* extract is attributed to its dopaminergic activity; specific diterpenes within the plant act as agonists at dopamine D2 receptors in the anterior pituitary, which inhibits the secretion of prolactin. By lowering elevated prolactin levels, Agnurell helps to normalize the luteal phase of the menstrual cycle and alleviate symptoms associated with hormonal imbalances.

Brand names
Agnurell
Other names
Agnus castus SanorellAgnurell-Sanorell Pharma
02

Targets

DRD2 (Dopamine D2 Receptor)

Beyond the preview

Go deeper on Agnurell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agnurell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call